IBO · Impact Biomedical Inc.
$0.46
+0.01 (+1.59%)
At close · Aug 25
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As reflected in the accompanying financial statements the Company has incurred operating losses as well as negative cash flows from operating activities over the past two years. These factors raise substantial doubt about the Company's ability to continue as a going concern within one year of the date that the financial statements are issued.”View the 10-Q filed Aug 7, 2026
Market Cap
$49.62M
Shares
107.82M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding IBO
5 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | — | 706,954 | $424,172 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 566,838 | $294,756 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | — | 236,904 | $123,190 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 154,944 | $80,571 | 0.00% | Long | 2026-05-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | AAXJ | 6 | $3 | 0.00% | Long | 2026-06-30 |
Showing 1–5 of 5 positions